| ²é¿´: 450 | »Ø¸´: 1 | |||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | |||
[ÇóÖú]
°ïÀϰåÉêÇëÒ»¸ö´óÏîÄ¿£¬Ðè·ÒëÒÔÏÂÎÄ×Ö¡£Ð»Ð»ÁË£¡
|
|||
|
1. ÓÃÒ©Áé»î£¬¿ÉÒÔµ÷½ÚÒ©Îï×é·Ö¼äµÄ±ÈÀý£¬²¢Óɴ˽Òʾ°Ð±êµÄ·Ö²¼¡¢Ç¿¶ÈÒÔ¼°°Ð±êµÄÉúÎﻯѧ¼ÁÁ¿¡£ 2. ×éºÏµÄÒ©ÎïÖÎÁÆÀàÐͺͻ¯Ñ§½á¹¹·Ç³£¹ã·º£¬Ëٶȿ졢ͶÈëµÍ¡£ 3. ʵÏÖ¸öÌ廯¸øÒ©£¬¸ù¾Ý»¼ÕßµÄÒ©ÀíÒÅ´«×éѧ£¬µ÷Õû²»Í¬µÄ×é·½ºÍ¼ÁÁ¿¡£ 4. ¿ÉÒÔʵÏÖÐò¹áÐÔ¸øÒ©£¬·¢»Ó×î´óµÄÖÎÁÆÐ§¹û¡£ |
» ²ÂÄãϲ»¶
²ÄÁÏ£¬·ÄÖ¯£¬ÉúÎ0856¡¢0710£©£¬»¯Ñ§ÕÐÉúÀ²
ÒѾÓÐ7È˻ظ´
301Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
281Çóµ÷¼Á£¨0805£©
ÒѾÓÐ7È˻ظ´
²ÄÁÏÓ뻯¹¤Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
299Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
277µ÷¼Á
ÒѾÓÐ6È˻ظ´
341Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
328Çóµ÷¼Á£¬Ó¢ÓïÁù¼¶551£¬ÓпÆÑоÀú
ÒѾÓÐ8È˻ظ´
293Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
070300»¯Ñ§319Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´

zcius
ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)
- ·ÒëEPI: 65
- Ó¦Öú: 5 (Ó×¶ùÔ°)
- ½ð±Ò: 16742.4
- É¢½ð: 810
- ºì»¨: 8
- Ìû×Ó: 8863
- ÔÚÏß: 406.9Сʱ
- ³æºÅ: 1123409
- ×¢²á: 2010-10-15
- רҵ: ¼ÆËã»ú¿ÆÑ§µÄ»ù´¡ÀíÂÛ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
°®ÓëÓêÏÂ(½ð±Ò+1): 2012-02-24 21:15:35
³ÁDZºÓ½(½ð±Ò+5, ·ÒëEPI+1): ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ 2012-02-24 22:02:46
³ÁDZºÓ½(½ð±Ò+5, ·ÒëEPI+1): ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ 2012-02-24 22:02:46
|
1. Flexible adjustment of the proportion of drug components, and thus reveal the target distribution, intensity and the target dose of biochemistry. 2. Extensive types of combination drug therapies and chemical structures, fast effects and low cost. 3. Individualized prescription and dosage according to the patient's genetic pharmacology group. 4. Sequential drug deliveries for the most effective treatment. |
2Â¥2012-02-24 19:23:01













»Ø¸´´ËÂ¥
5